This CPB has been revised to state that (i) leuprolide is considered experimental and investigational for menorrhagia, menstrual migraines, and myeloma, (ii) histrelin acetate implants are considered experimental and investigational for precocious puberty due to adrenal hyperplasia, and (iii) triptorelin is considered experimental and investigational for ovarian suppression in members with early breast cancer.